Method of treating skin ulcers with vectors encoding hepatocyte growth factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 10, 2011
Grant Date -
Nov 15, 2007
app pub date -
Jun 14, 2007
filing date -
May 9, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth f actor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully